Recruiting

Observational Study

Sponsor:

Priyanka Sharma

Code:

NCT06603597

Conditions

HER2 + Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.

Conditions

HER2 + Breast Cancer

Study ID

NCT06603597

Start date

Sep 27, 2024

Status verified date

Jul, 2026

Completion date

Oct, 2044

Anticipated

Primary completion date

Oct, 2044

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Stage I-IV HER2-positive breast cancer

Exclusion Criteria:

  • None

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Arms

HER2-positive breast cancer

Patients with stage I-IV HER2-positive breast cancer

Primary outcome measure

  • Overall survival rate [ Time Frame: From diagnosis to 5 years after diagnosis ]

Central Contacts and Locations

Central contacts

Study Coordinator

913-588-6079PRO-HER2@kumc.edu

Locations

The University of Kansas Cancer Center

Recruiting

Westwood, Kansas, United States, 66205

Contacts

Study Coordinator

913-588-6079PRO-HER2@kumc.edu

More Information

Sponsor

Priyanka Sharma

Last update posted

Jul 17, 2026

Last verified

Jul, 2026

Keywords

  • breast cancer
  • registry
  • HER2+
  • HER2 positive

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Priyanka Sharma on 2026-07-17.